Cargando…
Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients
BACKGROUND: Bevacizumab is an anti-vascular endothelial growth factor approved in association with paclitaxel or docetaxel as first line in patients (pts) with metastatic breast cancer. Rare cases of nasal septum perforations have been reported. We report our experience of nasal perforation in breas...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966623/ https://www.ncbi.nlm.nih.gov/pubmed/20736943 http://dx.doi.org/10.1038/sj.bjc.6605828 |